These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 16005602)

  • 61. Genetic predisposition syndromes and their management.
    Euhus DM; Robinson L
    Surg Clin North Am; 2013 Apr; 93(2):341-62. PubMed ID: 23464690
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Quality of life after contralateral prophylactic mastectomy in newly diagnosed high-risk breast cancer patients who underwent BRCA1/2 gene testing.
    Tercyak KP; Peshkin BN; Brogan BM; DeMarco T; Pennanen MF; Willey SC; Magnant CM; Rogers S; Isaacs C; Schwartz MD
    J Clin Oncol; 2007 Jan; 25(3):285-91. PubMed ID: 17159191
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors and outcomes of contralateral prophylactic mastectomy among breast cancer survivors.
    Graves KD; Peshkin BN; Halbert CH; DeMarco TA; Isaacs C; Schwartz MD
    Breast Cancer Res Treat; 2007 Sep; 104(3):321-9. PubMed ID: 17066320
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Lobulitis is a frequent finding in prophylactically removed breast tissue from women at hereditary high risk of breast cancer.
    Hermsen BB; von Mensdorff-Pouilly S; Fabry HF; Winters HA; Kenemans P; Verheijen RH; van Diest PJ
    J Pathol; 2005 Jun; 206(2):220-3. PubMed ID: 15880615
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Anticipatory loss and early mastectomy for young female BRCA1/2 mutation carriers.
    Hoskins LM; Greene MH
    Qual Health Res; 2012 Dec; 22(12):1633-46. PubMed ID: 22927701
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Family Systems genetic Illness Model--breast cancer.
    Baumann SL
    Clin J Oncol Nurs; 2006 Jun; 10(3):377-81. PubMed ID: 16789582
    [TBL] [Abstract][Full Text] [Related]  

  • 67. 'That's like chopping off a finger because you're afraid it might get broken': disease and illness in women's views of prophylactic mastectomy.
    Press N; Reynolds S; Pinsky L; Murthy V; Leo M; Burke W
    Soc Sci Med; 2005 Sep; 61(5):1106-17. PubMed ID: 15955410
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Improved overall survival after contralateral risk-reducing mastectomy in BRCA1/2 mutation carriers with a history of unilateral breast cancer: a prospective analysis.
    Heemskerk-Gerritsen BA; Rookus MA; Aalfs CM; Ausems MG; Collée JM; Jansen L; Kets CM; Keymeulen KB; Koppert LB; Meijers-Heijboer HE; Mooij TM; Tollenaar RA; Vasen HF; ; Hooning MJ; Seynaeve C
    Int J Cancer; 2015 Feb; 136(3):668-77. PubMed ID: 24947112
    [TBL] [Abstract][Full Text] [Related]  

  • 69. The impact of having relatives affected with breast cancer on psychological distress in women at increased risk for hereditary breast cancer.
    van Dooren S; Seynaeve C; Rijnsburger AJ; Duivenvoorden HJ; Essink-Bot ML; Bartels CC; Klijn JG; de Koning HJ; Tibben A
    Breast Cancer Res Treat; 2005 Jan; 89(1):75-80. PubMed ID: 15666200
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Indications for prophylactic mastectomy.
    Nemecek JR; Young VL; Lopez MJ
    Mo Med; 1993 Mar; 90(3):136-40. PubMed ID: 8446090
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Guidelines for the management of women at increased familial risk of breast cancer.
    Sauven P;
    Eur J Cancer; 2004 Mar; 40(5):653-65. PubMed ID: 15010065
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Clinical cancer genetics. Part 2: Breast.
    Pollock J; Welsh JS
    Am J Clin Oncol; 2014 Feb; 37(1):86-9. PubMed ID: 22307211
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Impact of BRCA1/BRCA2 counseling and testing on newly diagnosed breast cancer patients.
    Schwartz MD; Lerman C; Brogan B; Peshkin BN; Halbert CH; DeMarco T; Lawrence W; Main D; Finch C; Magnant C; Pennanen M; Tsangaris T; Willey S; Isaacs C
    J Clin Oncol; 2004 May; 22(10):1823-9. PubMed ID: 15067026
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Contralateral risk-reducing mastectomy in young breast cancer patients with and without genetic cancer risk assessment.
    Mai PL; Lagos VI; Palomares MR; Weitzel JN
    Ann Surg Oncol; 2008 Dec; 15(12):3415-21. PubMed ID: 18836779
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Personal health behaviors in women who have undergone risk-reducing mastectomy.
    Specht MC; Borgen PI; Fey J; Zhang Z; Sclafani L
    Am J Surg; 2004 Oct; 188(4):448-9. PubMed ID: 15474447
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Summaries for patients. Do women with breast cancer overestimate their risk for cancer in the unaffected breast?
    Ann Intern Med; 2013 Sep; 159(6):I-30. PubMed ID: 24042379
    [No Abstract]   [Full Text] [Related]  

  • 77. Uptake of screening and prevention in women at very high risk of breast cancer.
    Evans D; Lalloo F; Shenton A; Boggis C; Howell A
    Lancet; 2001 Sep; 358(9285):889-90. PubMed ID: 11567707
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Genetic Diagnosis before Surgery has an Impact on Surgical Decision in BRCA Mutation Carriers with Breast Cancer.
    Park S; Lee JE; Ryu JM; Kim I; Bae SY; Lee SK; Yu J; Kim SW; Nam SJ
    World J Surg; 2018 May; 42(5):1384-1390. PubMed ID: 29147896
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Prophylactic bilateral mastectomy and contralateral prophylactic mastectomy.
    Chagpar AB
    Surg Oncol Clin N Am; 2014 Jul; 23(3):423-30. PubMed ID: 24882342
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Coping with appraised breast cancer risk among women with family histories of breast cancer.
    Lancaster DR
    Res Nurs Health; 2005 Apr; 28(2):144-58. PubMed ID: 15779052
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.